Plasma and brain amino acids in fulminant hepatic failure and their relationship to hepatic encephalopathy.
about
Tryptophan metabolism, disposition and utilization in pregnancyBrain energy metabolism and mitochondrial dysfunction in acute and chronic hepatic encephalopathyα-Ketoglutaramate: an overlooked metabolite of glutamine and a biomarker for hepatic encephalopathy and inborn errors of the urea cyclePathogenesis of hepatic encephalopathy and brain edema in acute liver failureEvaluation of mannitol effect in patients with acute hepatic failure and acute-on-chronic liver failure using conventional MRI, diffusion tensor imaging and in-vivo proton MR spectroscopy.Brain edema in acute liver failure: inhibition by L-histidine.Glutamine as a pathogenic factor in hepatic encephalopathy.Treatment of encephalopathy during fulminant hepatic failure by haemodialysis with high permeability membrane.Plasma amino-acid patterns in liver diseaseEncephalopathy in acute liver failure resulting from acetaminophen intoxication: new observations with potential therapyBrain aquaporin-4 in experimental acute liver failure.Neurochemistry of hepatic encephalopathyBranched-chain amino acids in liver diseases.Hepatology - Guidelines on Parenteral Nutrition, Chapter 16.Role of astrocytes in brain function and disease.Use of the molecular adsorbent recirculating system (MARS™) for the management of acute poisoning with or without liver failure.Glutamine in the pathogenesis of hepatic encephalopathy: the trojan horse hypothesis revisited.Protein Requirements for Critically Ill Patients With Renal and Liver Failure.Therapeutic effects of methionine sulfoximine in multiple diseases include and extend beyond inhibition of glutamine synthetase.Glycine and hyperammonemia: potential target for the treatment of hepatic encephalopathy.Parenteral nutrition and coma therapy with amino acids in hepatic failure.Environmental, toxicological and related aspects of tryptophan metabolism with particular reference to the central nervous system.Amino acids in liver disease.Intra- and extracellular amino acid concentrations in portacaval-shunted rabbits. Role of hyperammonemia and effects of branched-chain amino acid-enriched parenteral nutrition.Serum hepatocyte growth factor as an index of extensive catabolism of patients awaiting liver transplantation.Rapid inhibition of DNA synthesis in hepatocytes from regenerating rat liver by serum from patients with fulminant hepatic failure.Brain edema and intracranial hypertension in fulminant hepatic failure: pathophysiology and management.Effect of acute exposure to ammonia on glutamate transport in glial cells isolated from the salamander retina.Plasma amino acids in cirrhosis and after liver transplantation: influence of liver function, hepatic hemodynamics and circulating hormones.[Nutrition and liver failure].Branched chain amino acid-enriched solutions in the septic patient. A randomized, prospective trial.Amino acids and indoleamines in the brain after infusion of branched-chain amino acids to rats with liver ischemia.Elevated plasma gamma-aminobutyric acid (GABA) levels in individuals with either Prader-Willi syndrome or Angelman syndrome.Combined or individual administration of branched-chain amino acids following total hepatectomy in the rat: effects on amino acids and indoleamines in brain.Glutamine, myo-inositol, and organic brain osmolytes after portocaval anastomosis in the rat: implications for ammonia-induced brain edema.
P2860
Q26783616-0D09FD5A-0723-450A-9A6F-85C3FE07432FQ26864631-508FA330-766A-4B0E-92A1-2F21AB9EC535Q26865272-AFADE0A4-95DC-4FEA-A4AA-C2DC8F62D7DEQ30965016-6890B48E-9F7E-4FF9-95FE-75FEA039FCFCQ31163349-9B50CD7F-9B23-49E0-8D95-771E271E1F9FQ33703761-880F2C40-1CAB-4A00-AE35-8BA569E51E9EQ34297156-F8CAF58C-5F24-4BF5-BA65-5E3CE6DBC914Q34474877-5FAB2E28-E3F8-441A-AC87-E73399D8B8C4Q34495040-F56BC9B7-A248-4DC3-81B2-F41E20179265Q35387099-01A3F4C8-1754-40E9-9EF0-6B3CDB2DA82EQ36533457-BAE4E175-D7F0-47C1-A83C-79B67D86B489Q36831314-B2818D31-6BBC-4E99-A629-ECFF01D958D6Q37334109-A440F350-22CF-4944-8FA9-465E2E413EA1Q37481692-BB23C4EF-0A22-4E81-A38F-0004F8F4D174Q37809408-2007A9CF-F5AA-4439-B64F-2359192D190CQ37955184-32DF013C-1B4A-424F-BA77-79809BA51484Q38070659-585D4637-BA8D-4CF3-8815-CBECFAC256D9Q39139047-497AD84F-50F1-43A8-B65A-3968C45F2870Q39177919-A9BAF89B-5771-417C-BADF-8ED2D44AFDF4Q39658369-0BFF2B3F-2144-45F7-941D-357FA65BCC40Q39684460-2DEE667E-2C8A-4B93-823A-937AC01D6FEBQ39710466-EBA4AA1D-97C2-4D82-9F38-7F59B17EEA18Q40166987-0E953B1F-3BA0-4E01-B945-4F4683748368Q41277019-87E2CD1E-9DCC-4249-A265-21EA04299EB4Q42132527-3B341E57-BD38-4705-9A8B-572F5EE57531Q42263520-C328784F-CAC0-4225-A4C3-4C7ACADC8AFAQ42726017-B06E2DDB-64A4-47F9-8617-595A5707D1D9Q43701698-0AE96D81-02F1-41EA-9072-4868026EEF4DQ43975343-6D805B83-3B25-4C19-815D-5E7F10DBE35FQ44175960-0E30C4AB-F008-4209-AE92-54CE8E10B683Q44656788-8CCBD509-CC99-4601-948E-7C9898B82453Q48308829-21CC0020-0C98-468B-989B-3D22F27CD47DQ48813406-19F91171-5A51-4B4C-B864-1D1C309F013EQ48908149-4E136B35-0767-435F-98FB-1FD355CF7E7DQ48910533-7CD80D73-5C1B-4645-96CB-5B2D5F948413
P2860
Plasma and brain amino acids in fulminant hepatic failure and their relationship to hepatic encephalopathy.
description
1976 nî lūn-bûn
@nan
1976年の論文
@ja
1976年論文
@yue
1976年論文
@zh-hant
1976年論文
@zh-hk
1976年論文
@zh-mo
1976年論文
@zh-tw
1976年论文
@wuu
1976年论文
@zh
1976年论文
@zh-cn
name
Plasma and brain amino acids i ...... hip to hepatic encephalopathy.
@en
Plasma and brain amino acids i ...... hip to hepatic encephalopathy.
@nl
type
label
Plasma and brain amino acids i ...... hip to hepatic encephalopathy.
@en
Plasma and brain amino acids i ...... hip to hepatic encephalopathy.
@nl
prefLabel
Plasma and brain amino acids i ...... hip to hepatic encephalopathy.
@en
Plasma and brain amino acids i ...... hip to hepatic encephalopathy.
@nl
P2093
P2860
P1476
Plasma and brain amino acids i ...... hip to hepatic encephalopathy.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2362.1976.TB00533.X
P577
1976-09-01T00:00:00Z